David Spiegelhalter is Winton Professor of the Public Understanding of Risk at the University of Cambridge and Senior Scientist in the MRC Biostatistics Unit. His background is in medical statistics, particularly the use of Bayesian methods in clinical trials, health technology assessment and drug safety. He led the statistical team in the Bristol Royal Infirmary Inquiry and also gave evidence to the Shipman Inquiry.